Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3Neoplasm Metastasis 2Stomach Neoplasms 1Pancreatic Adenocarcinoma 1Neoplasms 1Metastatic Pancreatic Adenocarcinoma 1Esophageal Neoplasms 1Carcinoma, Pancreatic Ductal 1

Interventions

Leucovorin 3Gemcitabine 3Fluorouracil 3pembrolizumab 2irinotecan sucrosofate 2Irinotecan 2Albumin-Bound Paclitaxel 24-fluorobenzoyl-TN-14003 2olaparib 1ibrutinib 1adavosertib 1Tetrahydrouridine 1Paclitaxel 1PEGPH20 1Oxaliplatin 1Drug Therapy 1Docetaxel 1Decitabine 1Cisplatin 1Capecitabine 1BKT140 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Metastatic Pancreatic Adenocarcinoma × PEGPH20 × Clear all
NCT01959139 2024-02-09

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

SWOG Cancer Research Network

Phase 1/2 Completed
126 enrolled 19 charts
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡